NextCell Pharma AB Logo

NextCell Pharma AB

Develops off-the-shelf cell therapies for autoimmune diseases like type 1 diabetes.

NXTCL | ST

Overview

Corporate Details

ISIN(s):
SE0009723125 (+1 more)
LEI:
549300PBFGB5JYKXGA45
Country:
Sweden
Address:
Hälsovägen 7, 141 57 Huddinge
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

NextCell Pharma AB is a biopharmaceutical company specializing in the development of novel stromal cell therapies for autoimmune and inflammatory diseases. The company's lead drug candidate, ProTrans, is an allogeneic, off-the-shelf cell therapy product based on its patented selection algorithm, primarily targeting the treatment of type 1 diabetes. In addition to its therapeutic pipeline, NextCell operates a biobank for the long-term storage of stem cells, including adipose (fat) tissue-derived cells. The company engages in strategic collaborations, notably with FUJIFILM Biosciences, and invests in adjacent technologies such as CAR-T to strengthen its position in the advanced therapy medicinal products sector.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all NextCell Pharma AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for NextCell Pharma AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Israel KVSR
Almirall S.A. Logo
A global biopharmaceutical company developing innovative medical solutions for skin health.
Spain ALM
Alteogen Inc. Logo
Biotech firm developing next-gen ADCs and biobetters with proprietary platform technologies.
South Korea 196170
Alvotech Holdings S.A Logo
Develops and manufactures affordable biosimilar medicines for global patient access.
Luxembourg ALVO
Alzinova AB Logo
Developing targeted immunotherapies, including a vaccine, for Alzheimer's disease.
Sweden ALZ
Biotech firm using enzyme tech for pharma, healthcare, and bioprocess CDMO services.
South Korea 092040
AMINOLOGICS CO.,LTD. Logo
Manufactures high-purity chiral amino acids & APIs for pharma, chemical, and food industries.
South Korea 074430
Amphastar Pharmaceuticals Inc. Logo United States of America AMPH
Develops approved cannabinoid medicines for pain, epilepsy, and heart failure.
United Kingdom N/A
Develops qPCR diagnostic kits and robotic automation systems for clinical and research laboratories.
Türkiye ANGEN

Talk to a Data Expert

Have a question? We'll get back to you promptly.